Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 2, 2022--
The "Gastrointestinal Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Gastrointestinal Therapeutics Market to Reach $84.4 Billion by 2027
The global market for Gastrointestinal Therapeutics estimated at US$61.2 Billion in the year 2020, is projected to reach a revised size of US$84.4 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027.
Crohn`s Disease, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$16.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Ulcerative Colitis segment is readjusted to a revised 4.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $16.5 Billion, While China is Forecast to Grow at 7.5% CAGR
The Gastrointestinal Therapeutics market in the U.S. is estimated at US$16.5 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$17.5 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$11.4 Billion by the year 2027.
GERD Segment to Record 5.1% CAGR
In the global GERD segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.1 Billion in the year 2020 will reach a projected size of US$7.1 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.5% CAGR through the analysis period.
What's New for 2022?
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/hhdnls
View source version on businesswire.com:https://www.businesswire.com/news/home/20221102005629/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/02/2022 08:54 AM/DISC: 11/02/2022 08:54 AM
http://www.businesswire.com/news/home/20221102005629/en